Hypersensitivity Pneumonitis: An Important but Often Underdiagnosed ILD
Course: #2187Level: Advanced 1 Hour 138 Reviews
Respiratory therapists play a vital role in managing interstitial lung diseases (ILDs) like hypersensitivity pneumonitis (HP). Despite its distinct pathophysiology, HP is frequently misdiagnosed as idiopathic pulmonary fibrosis (IPF), leading to significant prognostic and therapeutic implications. This course provides respiratory therapists with the essential knowledge and skills to differentiate between HP and IPF, emphasizing the importance of thorough patient history-taking and collaboration with multidisciplinary teams. By enhancing their diagnostic acumen, therapists can ensure timely recognition and appropriate management of HP, ultimately improving patient outcomes in the realm of ILDs.
On Demand
Course Type: Video
CEUs/Hours Offered: AARC - CRCE/1.0; CE Broker/1.0 Direct Delivery Of Respiratory Care Services, CE Broker #20-1240212; IACET/0.1
Course Preview
Watch the first six minutes of the course. Register for immediate access to the full course, which will also appear on your Pending Courses page.
Learning Outcomes
- After this course, participants will be able to describe what hypersensitivity pneumonitis (HP) is and its potential causes.
- After this course, participants will be able to explain the diagnostic approach to HP and the importance of identifying the presence or absence of fibrosis in HP.
- After this course, participants will be able to discuss the evidence-based approach to treatment, including current and potential future therapeutics.
Course created on August 19, 2024
Agenda
| 0-5 Minutes | Introduction |
| 5-15 Minutes | Definition of HP and its causes |
| 15-30 Minutes | Diagnostic Approach to HP |
| 30-45 Minutes | Evidence-based treatment options for HP |
| 45-55 Minutes | Exploration of potential future therapeutics and research directions |
| 55-60 Minutes | Summary, Q&A |
Reviews
138 ReviewsPresented By
Anoop Nambiar
MD, MS
Dr. Anoop M. Nambiar is a Professor of Medicine and Founding Director of the Center for Interstitial Lung Disease at the University of Texas Health Science Center at San Antonio and specializes in interstitial lung diseases. He completed his undergraduate studies at Rutgers University in New Jersey in 1999. He received his Doctor of Medicine in 2003 at New Jersey Medical School-University of Medicine and Dentistry of New Jersey. In 2006, he completed his internship and residency in internal medicine at the University of Michigan followed by fellowship in pulmonary and critical care medicine there. He is an active member of the American Thoracic Society, American College of Chest Physicians, and European Respiratory Society. His program is currently one of 68 Pulmonary Fibrosis Foundation Care Centers in the U.S., one of 5 in Texas, and the only one in South Texas.
More
Sponsor Disclosure: This Course is presented by Continued Respiratory Therapy.
Content Disclosure: This learning event does not focus exclusively on any specific product or service.
Course participation information
To ensure you are ready to participate, please complete our short Test Drive to prepare your computer to view the course.
NOTE: Full attendance for all courses is mandatory. Please view the entire course.
Passing an online exam and completing a course evaluation will be required to earn continuing education credit.
Live Webinars allow presenter and participant interaction. The exam and course evaluation for these courses must be completed within 7 days of the event.
On-demand courses include texts, video and audio recordings of live webinars, and multimedia formats. The exam and course evaluation for on-demand courses must be completed within 30 days of course registration.
To participate in the course, complete the exam and course evaluation, and earn continuing education credit, you must be a Continued Respiratory Therapy member. Participants must complete the entire course; partial credit is not allowed.
Continued Respiratory Therapy is committed to ensuring accessibility to the widest possible audience. We are continually improving the user experience for everyone. If you have questions, requests, or would like to report an accessibility-related issue, please email accessibility@continued.com. We will review your request and respond in a timely manner.
Visit our Contact us page or give us a call if you have questions.
American Association for Respiratory Care
This non-traditional program has been approved for a maximum of 1 contact hour(s) Continuing Respiratory Care Education (CRCE) credit by the American Association for Respiratory Care, 9425 N. MacArthur Blvd. Suite 100 Irving TX 75063. Course # 192593000
CE Broker
Continued Respiratory Therapy is an approved provider for CE Broker, provider #50-30700. This course is offered for 1.0 hours. If you are a licensed respiratory therapist in Alabama, Florida, Georgia, Kansas, Louisiana, Mississippi, New Hampshire, Oklahoma, South Carolina or Texas, CE Broker may be of interest to you. For Florida respiratory therapists, this course is registered in the Direct Delivery of Respiratory Care Services category.
International Association for Continuing Education and Training
Continued, LLC, is accredited by the International Association for Continuing Education and Training (IACET). Continued complies with the ANSI/IACET Standard, which is recognized internationally as a standard of excellence in instructional practices. As a result of this accreditation, Continued is authorized to issue the IACET CEU. Continued, LLC, is authorized by IACET to offer 0.1 CEUs for this program.
We recognize that state CE requirements are constantly changing. If you have any questions regarding our courses and your state requirements, please contact us at 866-382-0799 or contact Customer Service.